Skip to content

Clinical trials

Melanoma trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Country / region: Singapore Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20132
20154
20161
20172
20192
20202
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Completed5
Terminated4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Bayer2
Hoffmann-La Roche2
Eli Lilly and Company1
HUYABIO International, LLC.1
Inhibrx Biosciences, Inc1
Iovance Biotherapeutics, Inc.1
National Cancer Centre, Singapore1
Pfizer1
Sichuan Huiyang Life Science and Technology Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma18
Carcinoma, Non-Small-Cell Lung11
Carcinoma, Renal Cell6
Head and Neck Neoplasms4
Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Breast Neoplasms3
Colonic Neoplasms3
Colorectal Neoplasms3
Ovarian Neoplasms3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.